Current Hypotheses in Cardiac Surgery: Biofilm in Infective Endocarditis

Seminars in Thoracic and Cardiovascular Surgery

Volumn 28, Issue 1, 2016, Pages 56-59

  Elgharably, Haytham ^a   Hussain, Syed T ^a   Shrestha, Nabin K ^b   Blackstone, Eugene H ^a,c   Pettersson, Gösta B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Medicine Institute   (United States)

^c Research Institute   (United States)

Author keywords

biofilm; infective endocarditis; pathology; resistance; surgical treatment

Indexed keywords

ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ADHERENCE; BIOFILM; BLOOD CULTURE; DEBRIDEMENT; ENTEROCOCCUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; QUORUM SENSING; SERODIAGNOSIS; STAPHYLOCOCCUS; STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; BACTERIUM; CLASSIFICATION; DRUG EFFECTS; ENDOCARDITIS, BACTERIAL; GROWTH, DEVELOPMENT AND AGING; HEART SURGERY; HEART VALVE; MICROBIOLOGY; PATHOGENICITY; SURGERY;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CARDIAC SURGICAL PROCEDURES; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; HEART VALVES; HUMANS;

EID: 84956922638     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2015.12.005     Document Type: Article

References (25)

1. 1 Hoen, B., Duval, X., Clinical practice. Infective endocarditis. N Engl J Med 368 (2013), 1425–1433.
2. 2 Yusuf, S.W., Sharma, J., Durand, J.B., et al. Endocarditis and myocarditis: A brief review. Expert Rev Cardiovasc Ther 10 (2012), 1153–1164.
3. 3 Prendergast, B.D., Tornos, P., Surgery for infective endocarditis: Who and when?. Circulation 121 (2010), 1141–1152.
4. 4 Bjarnsholt, T., The role of bacterial biofilms in chronic infections. APMIS Suppl 121:Suppl 136 (2013), 1–51.
5. 5 Donlan, R.M., Costerton, J.W., Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002), 167–193.
6. 6 Wozniak, D.J., Parsek, M.R., Surface-associated microbes continue to surprise us in their sophisticated strategies for assembling biofilm communities. F1000Prime Rep, 6, 2014, 26.
7. 7 Korber, D.R., Lawrence, J.R., Lappin-Scott, H.M., et al. Growth of microorganisms on surfaces. Lappin-Scott, H.M., Costerton, J.W., (eds.) Microbial biofilms, 1995, Cambridge University Press, New York, 15–45.
8. 8 Lewis, K., Persister cells: Molecular mechanisms related to antibiotic tolerance. Handb Exp Pharmacol 211 (2012), 121–133.
9. 9 Marrie, T.J., Cooper, J.H., Costerton, J.W., Ultrastructure of cardiac bacterial vegetations on native valves with emphasis on alterations in bacterial morphology following antibiotic treatment. Can J Cardiol 3 (1987), 275–280.
10. 10 Bosio, S., Leekha, S., Gamb, S.I., et al. Mycobacterium fortuitum prosthetic valve endocarditis: A case for the pathogenetic role of biofilms. Cardiovasc Pathol 21 (2012), 361–364.
11. 11 Kohler P, Kuster SP, Bloemberg G, et al. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J 36:2745-2753, 2015.
12. 12 Speziale, P., Geoghegan, J.A., Biofilm formation by Staphylococci and Streptococci: Structural, functional, and regulatory aspects and implications for pathogenesis. Front Cell Infect Microbiol, 5, 2015, 31.
13. 13 Mohamed, J.A., Huang, D.B., Biofilm formation by Enterococci. J Med Microbiol 56 (2007), 1581–1588.
14. 14 Presterl, E., Grisold, A.J., Reichmann, S., et al. Viridans streptococci in endocarditis and neutropenic sepsis: Biofilm formation and effects of antibiotics. J Antimicrob Chemother 55 (2005), 45–50.
15. 15 Fey, P.D., Ulphani, J.S., Gotz, F., et al. Characterization of the relationship between polysaccharide intercellular adhesin and hemagglutination in Staphylococcus epidermidis. J Infect Dis 179 (1999), 1561–1564.
16. 16 Chuang-Smith, O.N., Wells, C.L., Henry-Stanley, M.J., et al. Acceleration of Enterococcus faecalis biofilm formation by aggregation substance expression in an ex vivo model of cardiac valve colonization. PLoS One, 5, 2010, e15798.
17. 17 Chifiriuc, M.C., Banu, O., Bleotu, C., et al. Interaction of bacteria isolated from clinical biofilms with cardiovascular prosthetic devices and eukaryotic cells. Anaerobe 17 (2011), 419–421.
18. 18 Parsek, M.R., Singh, P.K., Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 57 (2003), 677–701.
19. 19 Naber, C.K., Erbel, R., Infective endocarditis with negative blood cultures. Int J Antimicrob Agents 30 (2007), S32–S36 (suppl 1).
20. 20 Selan, L., Passariello, C., Rizzo, L., et al. Diagnosis of vascular graft infections with antibodies against staphylococcal slime antigens. Lancet 359 (2002), 2166–2168.
21. 21 Shrestha, N.K., Ledtke, C.S., Wang, H., et al. Heart valve culture and sequencing to identify the infective endocarditis pathogen in surgically treated patients. Ann Thorac Surg 99 (2015), 33–37.
22. 22 Marin, M., Munoz, P., Sanchez, M., et al. Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine 86 (2007), 195–202.
23. 23 Simoes, M., Antimicrobial strategies effective against infectious bacterial biofilms. Curr Med Chem 18 (2011), 2129–2145.
24. 24 Chen, M., Yu, Q., Sun, H., Novel strategies for the prevention and treatment of biofilm related infections. Int J Mol Sci 14 (2013), 18488–18501.
25. 25 Wolcott, R.D., Rhoads, D.D., A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 17 (2008), 54–55.